Logical Therapeutics
Waltham
About Logical Therapeutics
Logical Therapeutics, Inc., a biopharmaceutical company, engages in the development of drugs to treat diseases caused by or associated with excessive inflammation. Its products include LT-NS001, a non-steroidal anti-inflammatory drug for the treatment of chronic inflammatory conditions, such as osteoarthritis; Leptin, a hormone for the regulation of normal body mass and metabolism; and TNF, a hormone that promotes the proliferation of hepatocytes. The company was founded in 2005 and is based in Waltham, Massachusetts.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $79.4M
- Funding stage: Late Stage Venture
- Last round: Series C (May 2010)
- Website: logicaltx.com
- Phone: (781)290-0900
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/logical-therapeutics-2763191 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.